A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community

Despite research conducted worldwide, there is no treatment specifically targeting SARS-CoV-2 infection with efficacy proven by randomized controlled trials. A chance for a breakthrough is vaccinating most of the global population. Public opinion surveys on vaccine hesitancy prompted our team to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Grochowska, Magdalena, Ratajczak, Aleksandra, Zdunek, Gabriela, Adamiec, Aleksander, Waszkiewicz, Paweł, Feleszko, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150871/
https://www.ncbi.nlm.nih.gov/pubmed/34066790
http://dx.doi.org/10.3390/vaccines9050475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150871/
https://www.ncbi.nlm.nih.gov/pubmed/34066790
http://dx.doi.org/10.3390/vaccines9050475

Ejemplares similares